| Abstrakt: |
A recent report from Stony Brook University Hospital highlights the importance of neuroprotection in the treatment of stroke. While endovascular thrombectomy has been successful in reducing mortality rates, functional outcomes for patients remain suboptimal. The researchers suggest that adjunctive therapies, such as neuroprotective agents that prevent oxidative stress, could improve stroke care. Additionally, the study emphasizes the significance of sedation and blood pressure management in endovascular thrombectomy for better stroke outcomes. The researchers propose a combined approach of endovascular therapy and neuroprotection to target disability caused by stroke. [Extracted from the article] |
